Clinical Trial Update: Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild Type [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating YQ1 plus cisplatin-based chemotherapy in advanced non-small cell lung cancer with EGFR wild-type status. The current trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• YQ1

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Epithelial Growth Factor Receptor Negative Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN